Clinical studies recruiting near Westbury

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Virtual Cycling Environments for Persons With Parkinson Disease
NA · New York Institute of Technology · Rutgers, The State University of New Jersey · NCT04804202 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Clinical Research Alliance ( Site 0086) · Merck Sharp & Dohme LLC · NCT06393374 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Clinical Research Alliance · Hoffmann-La Roche · NCT06793215 A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
Phase 3 · Clinical Research Alliance Inc. · argenx · NCT06544499 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · Clinical Research Alliance Inc · Regeneron Pharmaceuticals · NCT06091865 A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic So
Phase 1/Phase 2 · Clinical Research Alliance, Inc · Daiichi Sankyo · NCT06330064 A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS
Phase 3 · Clinical Research Alliance NY · Takeda · NCT06499285 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-
Phase 2 · Optum Medical Care, PC ( Site 0122) · Merck Sharp & Dohme LLC · NCT06890884 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06627647 Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macul
Phase 3 · Vitreoretinal Consultants of NY · 4D Molecular Therapeutics · NCT07064759 Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Phase 2 · Long Island Vitreoretinal Consultants · ONL Therapeutics · NCT06659445 A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compar
Phase 3 · Optum Medical Care, Pc · BeOne Medicines · NCT06943872 Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Phase 3 · Optum Medical Care, PC · Nuvalent Inc. · NCT06765109 A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Phase 3 · Optum Medical Care, PC ( Site 0009) · Merck Sharp & Dohme LLC · NCT07060807 AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
Phase 1 · Optum Medical Care PC · Carna Biosciences, Inc. · NCT05602363 Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
NA · New York Institute of Technology · New York Institute of Technology · NCT01765777 The Lily Device Trial
NA · Clinical Research Alliance · Luminate Medical, Inc. · NCT06786078 Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-sm
Phase 3 · Clinical Research Alliance · Daiichi Sankyo · NCT06899126 Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combinatio
Phase 1 · Clinical Research Alliance · InnoCare Pharma Inc. · NCT06351527 An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Pat
Phase 4 · Research Site · AstraZeneca · NCT07357597 A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Len
Phase 3 · Clinical Research Alliance Inc · Regeneron Pharmaceuticals · NCT06149286 Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy o
Phase 3 · Research Site · AstraZeneca · NCT06380751 Effects Of Osteopathic Manipulative Medicine(OMM) On Lower Extremity Muscle Characteristics In Parkinson's Disease(PD) P
NA · NYIT College of Osteopathic Medicine · New York Institute of Technology · NCT05884944 Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Phase 1/Phase 2 · Clinical Research Alliance · Revolution Medicines, Inc. · NCT06162221 A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lympho
Phase 3 · Optum Medical Care, Pc · BeOne Medicines · NCT06846671 Ketorolac Levels in Vitreous and Aqueous Samples From Patients Undergoing Combined Cataract and Pars Plana Vitrectomy Su
EARLY_Phase 1 · Ophthalmic Consultants of Long Island · DHS Consulting · NCT06539637 Examining Executive Functions in Medical Students Across Different Types of Study Breaks
NA · NYIT · New York Institute of Technology · NCT06710678 Comparing Efficacy of Osteopathic Manipulation vs. Wrist Immobilization for Carpal Tunnel Syndrome
NA · New York Institute of Technology · New York Institute of Technology · NCT07432750

Look up another city

Look up another condition